SCOTUS Preserves Abortion Pill Access
In a pivotal 9-0 decision on June 13, 2024, the U.S. Supreme Court unanimously rejected a challenge to the FDA's regulations for mifepristone, securing continued widespread access to the abortion pill across the nation. The Court ruled that anti-abortion groups lacked legal standing to sue, thereby maintaining the drug's availability under current FDA rules and averting a significant disruption to reproductive healthcare.